Learn More about Sponsors, Resources, & OCRA
Before the conference begins, check out dedicated areas to learn more about OCRA programs, trusted resources, and generous sponsors.

12:45PM
Welcome and Opening Remarks
Welcome! Audra Moran, President & CEO of Ovarian Cancer Research Alliance, will share updates as we kick off three special days of learning and connection.
Speaker: Audra Moran, President & CEO of Ovarian Cancer Research Alliance

2:00PM
Gyn Cancer 2025 SGO Goals of Care
Karen Lu, MD, current President of the Society of Gynecologic Oncology, will share important research and treatment updates.
Speaker: Karen Lu, MD

3:00PM
Sponsored Session
Talking Clinical Trials: AstraZeneca

3:00PM
Sponsored Session
Talking Clinical Trials: Natera Oncology

3:30PM
Sponsored Session
Talking Clinical Trials: Corcept Therapeutics

3:30PM
Sponsored Session
Talking Clinical Trials: PMV Pharma

4:00PM
Oncofertility
In this session, Joseph Letourneau, MD, will discuss oncofertility and how to make informed decisions about your reproductive future before, during, and after cancer treatment.
Speaker: Joseph Letourneau, MD

4:00PM
Hungry for Data – The Connection between Diet and Cancer and Selected Topics In Integrative Gynecologic Oncology
Learn more about integrative therapies that complement conventional treatment for gynecologic cancers. In this session, Tara Berman, MD, MS, will share the most up to date research in the field, discussing effective strategies to enhance quality of life and optimize treatment outcomes.
Speaker: Tara Berman, MD, MS

5:00PM
Chemo Brain — It’s Not All In Your Head!
In this presentation with Oncology Social Worker, Linda Hutkin-Slade, learn more about cancer related cognitive impairment or chemobrain and strategies to cope with it.
Speaker: Linda Hutkin-Slade, MSW, LCSW, OSW-C

6:00PM
Community Connections
OCRA Oncology Social Workers will host this interactive session at the close of each day. Please join them for an opportunity to participate in fun group activities while building new, lasting connections.
Leaders: OCRA Patient Support Team

10:00AM
Reflections: Time to Remember
A time to come together remember those that have died, those we are missing, those we have lost touch with, and those that we want to send our energy to.
Leaders: Tracy Moore, LCSW, and Nancy Cincotta, LCSW, MPhil.

11:00AM
Precision Medicine, Imprecise Access: Disparities in Hereditary Cancer Testing
In this session, Tuya Pal, MD, will highlight the critical role of genetic testing and ongoing follow-up care for individuals with hereditary predispositions. Dr. Pal will also address the disparities that impact access to essential genetic services.
Speaker: Tuya Pal, MD

12:00PM
ABCs of ADCs: Exciting Data on Efficacy and Safety
Learn about the latest advances in antibody-drug conjugates (ADCs) for gynecologic cancers. In this session, Bradley Monk, MD, FACOG, FACS, and Ursula Matulonis, MD, will present data on the efficacy and safety of ADCs, along with practical insights on managing treatment-related symptoms to enhance patient outcomes and quality of life.
Speakers: Bradley Monk, MD, FACOG, FACS; and Ursula Matulonis, MD

12:00PM
Advances in Endometrial Cancer
In this session, Bhavana Pothuri, MD, MS, will provide an overview of endometrial cancer, along with the standard and newer therapies available.
Speaker: Bhavana Pothuri, MD, MS

12:00PM
Treatment Advances for Rare Gynecologic Cancers
Ovarian cancer is a rare diagnosis in and of itself, and having a rare form of ovarian cancer can be daunting when seeking out critical information on your pathology and treatment options. In this session, John Farley, MD, will share about treatment advances for rare gynecologic cancers.
Speaker: John Farley, MD

12:00PM
Advances in Cervical Cancer
This session, led by Dmitriy Zamarin, MD, PhD, will provide an overview of management of cervical cancer and will discuss novel approved and emerging therapies.
Speaker: Dmitriy Zamarin, MD, PhD

1:00PM
Ask the Experts: Part 1
Our live panel of experts answer your important questions about ovarian and gynecologic cancer research, treatment, and survivorship.
Speakers: Amanda Fader, MD, Moderator; Panelists include current and former Bridges Scholars: Nicole Marjon, MD, Abigail Zamorano, MD, Shannon Armbruster, MD, Katherine Kurnit, MD, MPH, and Michael Toboni, MD

2:00PM
Ask the Experts: Part 2
Our live panel of experts answer your important questions about ovarian and gynecologic cancer research, treatment, and survivorship.
Speakers: Amanda Fader, MD, Moderator; Panelists include current and former Bridges Scholars: Nicole Marjon, MD, Abigail Zamorano, MD, Shannon Armbruster, MD, Katherine Kurnit, MD, MPH, and Michael Toboni, MD

3:00PM
Sponsored Session
Talking Clinical Trials

3:00PM
Sponsored Session
Talking Clinical Trials: GRAIL

3:30PM
Sponsored Session
Talking Clinical Trials

3:30PM
Sponsored Session
Talking Clinical Trials: Genelux

4:00PM
Sexual Health and Intimacy: Next Steps for Recovery
Please join us for a frank conversation around sexual health and finding ways to regain intimacy after cancer. Sharon Bober, PhD, will address your concerns and answer your questions about strategies to improve your physical, emotional, and sexual well-being.
Leaders: Sharon Bober, PhD

5:00PM
Managing Recurrence
Please join us for a presentation on the management of recurrent ovarian cancer, including an opportunity to ask your questions about the changing treatment landscape.
Speakers: Sarah Adams, MD

6:00PM
Community Connections
OCRA Oncology Social Workers will host this interactive session at the close of each day. Please join them for an opportunity to participate in fun group activities while building new, lasting connections.
Leaders: OCRA Patient Support Team

11:00AM
HER-2 Positive Gyn Cancer Treatments
Learn about more about targeted treatment options that specifically address the HER-2 Positive subtype with Kathleen Moore, MD, MS, FASCO. Learn how these targeted therapies work, their benefits, and potential side effects.
Speaker: Kathleen Moore, MD, MS, FASCO

11:00AM
Tumor-agnostic Approach to Cancer Care
Please join us for a discussion about the tumor agnostic approach to cancer care. Dr. Alison Schram will discuss what that means, how genomic testing can help and how targeted therapies improve treatment outcomes, focusing on implications in gyn cancer care.
Speaker: Alison Schram, MD

12:00PM
Rethinking Platinum Resistance
In this session, Stephanie Blank, MD, will review the latest therapies available for patients with platinum-resistant ovarian cancer.
Speakers: Stephanie Blank, MD

11:00PM
Low-Grade Serous Ovarian Cancer Update
Rachel Grisham, MD, and David Gershenson, MD, will provide an accessible overview of current and emerging approaches tailored specifically for low-grade serous ovarian cancer.
Speakers: Rachel Grisham, MD, and David M. Gershenson, MD

1:00PM
Family Communication: From the Littles to the Bigs
Cancer is an intensely personal experience, and yet also impacts the whole family. Karen Hurley, PhD, will discuss how to navigate family communication, from juggling roles during treatment, to having age-appropriate talks with young children through supportive communication with family members at any age.
Speaker: Karen Hurley, PhD

2:00PM
A Family Affair: Conversation About Hereditary Cancer
This panel conversation will explore the tangible and emotional impacts of inherited cancer.
Speakers: Nancy Cincotta, LCSW, MPhil + panel

3:00PM
Sponsored Session
Talking Clinical Trials: AbbVie

3:00PM
Sponsored Session
Talking Clinical Trials

3:30PM
Resilience Through Life Challenges and Changes
Please join us for an empowering session on building resilience through life’s challenges and changes. Rab Razzak, MD, FAAHPM, will share guidance on building emotional strength, adapting to new realities, and finding hope and meaning throughout the cancer journey.
Speaker: Rab Razzak, MD, FAAHPM

4:30PM
Closing Remarks
OCRA President and CEO, Audra Moran will provide closing remarks and acknowledgements.
Speaker: Audra Moran, President & CEO of Ovarian Cancer Research Alliance

4:35PM
Voices of Hope
Survivors share their thoughts about the importance of research, advocacy, support, and community.

(directly following closing remarks and Voices of Hope)
Community Connections
OCRA Oncology Social Workers will host this interactive session at the close of each day. Please join them for an opportunity to participate in fun group activities while building new, lasting connections.
Leaders: OCRA Patient Support Team

OCRA’s International Gynecologic Cancer Conference is the largest and longest running conference focused on ovarian cancer, now with expanded sessions for those affected by related gynecologic cancers. The conference brings together patients, caregivers, survivors, advocates and friends to learn about the latest developments in research, diagnosis, treatment and quality of life. All members of the ovarian and gynecologic cancer community are welcome. Opportunities are also available for sponsorship.

Yes, this is the same annual conference. We have updated the conference name to reflect all the sessions, support and resources offered for those facing ovarian cancer, as well as the broader gynecologic cancer community.

OCRA’s conference is held online, so anyone from anywhere can join.

OCRA’s 2025 International Gynecologic Cancer Conference will be free for all attendees.

The 2025 agenda is currently in development. In the meantime, you can view the 2024 program to see the range of topics and sessions offered.

All registered attendees will be provided a link for viewing the conference presentations.

Please view our sponsorship prospectus to discover opportunities for your company/organization to support the International Conference. For questions or more information on sponsorship opportunities, please contact jhughson-andrade@ocrahope.org.

We are happy to answer any questions you have. Just email conference@ocrahope.org or call (212) 268-1002 and our conference team will assist you.